Erratum: Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III Trial

J Clin Oncol. 2023 Jun 26:JCO2301230. doi: 10.1200/JCO.23.01230. Online ahead of print.NO ABSTRACTPMID:37364217 | DOI:10.1200/JCO.23.01230
Source: Clinical Breast Cancer - Category: Cancer & Oncology Source Type: research